WuXi Biologics Achieves Leadership Level in 2023 CDP Climate Change Assessment
- Written by PR Newswire
SHANGHAI, March 5, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced it has been recognized for outstanding performance in the 2023 Climate Change Assessment conducted by the global environmental non-profit CDP, achieving the Leadership...
Read more: WuXi Biologics Achieves Leadership Level in 2023 CDP Climate Change Assessment














